Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Curasan

Curasan
1988 FOUNDED
PUBLIC STATUS
31-40 EMPLOYEES
CUR STOCK SYMBOL
1 INVESTMENTS
$0.46 SHARE PRICE (As of Tuesday Closing)
Description

curasan AG is a Germany based company engaged in developing, producing and marketing of biomaterials and medical devices for bone and tissue regeneration. It is focused on biomimetic bone grafting materials for the use in orthopedics, traumatology, spine surgery and dental implantology. The group offers product pipeline for bone and tissue regeneration under the CERASORB brand. Other areas of application in the product range include products for are wound healing and osteoarthritis therapy.

Website
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Stock Exchange
ETR
Primary Office
  • Lindigstra├če 4
  • 63801 Kleinostheim
  • Germany

+49 06027 0000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Curasan’s full profile, request a free trial.

Curasan Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.36 - $1.39 $8.46M $0.47 -$0.39 13K 18.4M

Curasan Financials Summary

In Thousands,
USD
TTM
31-Dec-2018
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 8,089 8,089 20,486 10,510
Revenue 6,894 6,894 7,664 7,194
EBITDA (4,889) (4,889) (2,499) (2,372)
Net Income (6,350) (6,350) (4,509) (2,306)
Total Assets 12,879 12,879 17,453 13,266
Total Debt 654 654 318 2
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Curasan Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Curasan‘s full profile, request access.

Request full access to PitchBook

Curasan Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000000 18-Mar-2013 000000000000000000 Medical Supplies
To view this company’s complete investment and acquisition history, request access »

Curasan Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Curasan‘s full profile, request access.

Request full access to PitchBook

Curasan Executive Team (2)

Name Title Board
Seat
Contact
Info
Michael Schlenk Chief Executive Officer
Christine Uekert Chief Financial Officer